Overall Technical outlook

Price Summary

The stock of Concord Biotech Limited experienced a -2.94% plunge, showcasing a mediocre market performance.
Concord Biotech Limited's stock, on 2026-02-02 opened at 1142.6, climbed to a high of 1149.8, dropped to a low of 1100.0, and closed up -2.94% at 1109.0, with 64929 shares traded.
The top price for the stock in the last 52 weeks is 2345.6, with the bottom price being 1109.0.
The future price of CONCORDBIO is projected to range from 1290.0 to 1680.0, with an average expected price of 1545.8334, according to 6 analysts.

Technicals


Aroon: The persistent bearish trend in Aroon, with Aroon Down still at the 100 level, suggests continued weakness. To gain a complete understanding of this trend, it should be explored further in conjunction with other technical indicators.
CONCORDBIO aroon 871349
Aroon chart for Concord Biotech Limited


Bol. Bands: The price has crossed below the lower Bollinger Band, indicating a potential oversold condition in the market. This downward movement suggests that selling pressure has been strong enough to push prices below a critical support level. While the breach could mean the bearish trend will continue, it also raises the possibility of a reversal if buyers step in at these lower levels.
CONCORDBIO bbands 871349
Bolinger Bands chart for Concord Biotech Limited


Parabolic SAR: The PSAR maintains its bearish stance, setting a strong resistance level that could limit any potential upward movement. This ongoing bearish outlook suggests that the market may continue to face resistance, making it difficult to achieve significant gains for Concord Biotech Limited.
CONCORDBIO psar 871349
Parabolic Stop and Reverse chart for Concord Biotech Limited


Stochastic: With the Stochastic K-line under the D-line and below 20, the market shows a mildly bearish trend. This positioning suggests that CONCORDBIO may face some downside risk, though the bearish signal is not particularly strong. Traders should consider this as a cautious indicator.
CONCORDBIO stoch 871349
Stochastic chart for Concord Biotech Limited


Tripple Moving Agerage: The alignment of the 20-50-100 period moving averages suggests a bullish trend, but the slopes of the faster averages hint at a potential reversal. The weakening signals from these shorter-term averages indicate that the current upward momentum may be fading, suggesting that a change in direction could be near.
CONCORDBIO trippleSMA 871349
Tripple SMA chart for Concord Biotech Limited


Understanding a company's fundamentals—such as revenue, earnings, and debt levels—provides a solid foundation for analyzing its technical performance. Similarly, knowledge of the industry, including key competitors and market trends, is critical. Combining this fundamental analysis with technical indicators like stock charts, moving averages, and trading volume enables a more comprehensive approach to evaluating the company's overall health and potential future performance.